Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
Native American tribal organizations (other)Nonprofits having 501(c)(3) statusNonprofits without 501(c)(3) statusPrivate institutions of higher educationIndividualsFor-profit organizationsSmall businessesOthersUnrestrictedState governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic/State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities
552 grants for Native American tribal governments (Federally recognized)
Sorted by deadline (soonest first)
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
HHS-NIH11 · PAR-25-096
Closes Nov 17, 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-371
Closes Nov 18, 2026
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
HHS-NIH11 · PAR-25-369
Closes Nov 18, 2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
HHS-NIH11 · PAR-25-052
Closes Nov 19, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
HHS-NIH11 · PAR-25-226
Closes Nov 19, 2026
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
HHS-NIH11 · PA-23-317
Closes Nov 24, 2026
National Center for Construction Safety and Health Research and Translation (U54)
HHS-CDC-HHSCDCERA · RFA-OH-24-001
Closes Dec 1, 2026
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
HHS-NIH11 · RFA-OD-27-008
Closes Dec 2, 2026
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
HHS-NIH11 · RFA-OD-24-011
Closes Dec 4, 2026
NEA Arts and Artifacts Domestic Indemnity Program 1, FY2027 (12/26)
NEA · 2027FCAHDOM01
Closes Dec 7, 2026
Fiscal Year 2024 Flood Mitigation Assistance Swift Current
DHS-DHS · DHS-24-MT-144-000-99
Closes Dec 30, 2026
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-221
Closes Jan 7, 2027
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
HHS-NIH11 · PAR-25-098
Closes Jan 7, 2027
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
HHS-NIH11 · PAR-25-378
Closes Jan 7, 2027
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-379
Closes Jan 7, 2027
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-256
Closes Jan 7, 2027
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
HHS-NIH11 · PAR-25-159
Closes Jan 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-069
Closes Jan 7, 2027
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-310
Closes Jan 7, 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-167
Closes Jan 7, 2027
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-081
Closes Jan 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
HHS-NIH11 · PAR-25-025
Closes Jan 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-026
Closes Jan 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-070
Closes Jan 7, 2027
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
HHS-NIH11 · PAR-25-032
Closes Jan 7, 2027